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Abstract
Introduction: Kawasaki disease is an idiopathic acute systemic vasculitis of childhood. Although it
simulates the clinical features of many infectious diseases, an infectious etiology has not been
established. This is the first reported case of Kawasaki disease following Rocky Mountain spotted
fever.
Case presentation: We report the case of a 4-year-old girl who presented with fever and petechial
rash. Serology confirmed Rocky Mountain spotted fever. While being treated with intravenous
doxycycline, she developed swelling of her hands and feet. She had the clinical features of Kawasaki
disease which resolved after therapy with intravenous immune globulin (IVIG) and aspirin.
Conclusion: This case report suggests that Kawasaki disease can occur concurrently or immediately
after a rickettsial illness such as Rocky Mountain spotted fever, hypothesizing an antigen-driven
immune response to a rickettsial antigen.
Introduction
Kawasaki disease (KD) is an acute febrile systemic
vasculitis of childhood and is the leading cause of acquired
heart disease in children in the United States and Japan
[1]. Despite the availability of effective therapy to prevent
cardiac complications, KD still remains an etiologic
enigma. Although many epidemiologic and laboratory
studies have looked at the linkage of Kawasaki disease to
an infectious etiology, none of these associations has been
proven [2]. We describe a patient who was diagnosed with
R o c k yM o u n t a i ns p o t t e df e v e r( R M S F )a n dt r e a t e d
successfully. During her acute illness, she developed
clinical features of Kawasaki disease, which resolved with
intravenous immune globulin (IVIG) and aspirin therapy.
Case presentation
A 4-year-old Caucasian girl was admitted to hospital with
fever, rash and bilateral conjunctival injection without eye
discharge. Four days before hospitalization, she developed
fever and a diffuse, non-itchy, erythematous rash on her
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noticed a dog tick attached to her scalp. She was seen in
the emergency room and the tick was removed. She
developed vomiting and non-bloody diarrhea on the
following day. The next day, she developed redness of
both eyes without any discharge. She also complained of
pain in both her knees and her ankles while walking. She
had no significant past medical illness. She had received
all vaccinations appropriate for her age including second
dose MMR (measles, mumps, rubella) vaccine. The family
had a dog in the house. There was no history of any travel.
None of her family members were ill during or preceding
her illness.
On admission, she had fever of 39.4 ºC. Her heart rate was
110/minute and her blood pressure was 82/58 mmHg.
She had bilateral bulbar conjunctival injection without
discharge. Her pharynx was slightly injected without any
significant tonsillar enlargement, strawberry tongue or
erythema of her lips. Her neck was supple without cervical
lymphadenitis. Examination of her cardiac and respiratory
systems was normal. Her abdomen was soft with her liver
palpable 1 cm below the right costal margin. She had both
a blanching macular and a petechial rash on her trunk and
extremities including palms and soles (Figures 1 and 2).
Her laboratory results showed WBC 3500/mm
3 (5500-
15,500/mm
3), 48% polymorphonuclear leucocytes, 1%
bandform, 45% lymphocytes, 6% monocytes, hemoglo-
bin 8.9 gm/dL (11.5-12.5 gm/dl), hematocrit 24.7% (35-
40%),plateletcount51,000/mm
3(150,000-350,000/mm
3),
ESR 52 mm/hour (4-20 mm/hour), sodium 130 mmol/
L (133-146 mmol/L), alanine aminotransferase 178 IU/L
(10-40 IU/L), aspartate aminotransferase 178 IU/L
(1-50 IU/L), gamma glutamyl transferase (GGT)
94 IU/L (0-23 IU/L), direct bilirubin 1.3 gm/dL
(0.3-1.2 mg/dL), normal urine analysis. A throat culture
and ASO titers were normal. The cerebrospinal fluid
(CSF) analysis showed protein of 31 mg/dL (5-40 mg.dL),
glucose of 45 mg/dL (40-80 mg/dL), red blood cell
count of 1/mm
3, white blood cell count of 37/mm
3
(0-7 WBC/mm
3), 85% polymorphonuclear cells and 15%
mononuclearcells.Bloodculture,urinecultureandserology
for RMSF, leptospirosis and ehrlichiosis were dispatched.
Her chest radiogram was normal.
She was treated empirically on intravenous doxycycline for
presumptive diagnosis of RMSF along with ceftriaxone for
possible bacterial sepsis. Over the next 48 hours, she
became less febrile and her rash improved. But she had
some residual macular rash without any worsening or new
rash. RMSF IgM antibody was equivocal and IgG antibody
was negative by ELISA. The blood, cerebrospinal fluid and
urine culture remained negative and ceftriaxone was
discontinued. After 1 week of her illness, her electro-
cardiogram (ECG) was normal and she had a small
posterior/inferior pericardial effusion on echocardiogram.
On the ninth day of illness, she became very irritable. Her
lips appeared erythematous. She developed redness and
non-pitting swelling of her hands and feet. She received
IGIV at a dose of 2 g/kg along with aspirin at a dose of
100 mg/kg/day for Kawasaki disease. Over the next
12 hours, she became afebrile. Swelling of her hands and
feet resolved in 48 hours and the macular rash resolved
completely within 72 hours following IGIV therapy. Her
pancytopenia resolved in 48 hours after IGIV therapy. She
was discharged after 1 week of hospitalization. Her clinical
course, hematologic parameters and echocardiogram have
been normal on follow-up. Her serology for Epstein–Barr
virus, group A Streptococcus, and leptospira infection was
Figure 1. Rash on upper extremity.
Figure 2. Rash on lower extremity.
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chain reaction (PCR) were negative. She received high-
dose aspirin (80 mg/kg/day) until she remained afebrile
for 96 hours following which she was placed on low-dose
aspirin (4 mg/kg/day) for 6 weeks. Her ECG and
echocardiogram were normal at 3 and 6 weeks after the
onset of her illness.
RMSF antibody results
On the 6th day of illness: (ELISA) IgM-equivocal, IgG-
negative. On the 12th day of illness: (ELISA) IgM-positive,
IgG-equivocal. In the 5th week after onset of illness:
(ELISA) IgM-positive, IgG-positive; (IFA) IgM: >1:1024,
IgG 1:512.
An RMSF antibody titer (IFA) less than 1:64 is considered
negative. RMSF antibody by ELISA was done at ARUP
laboratory (Salt Lake City, UT, USA) and IFA was done at
Nicholas Institute (San Juan Capistrano, CA, USA).
Discussion
Our patient presented with a history of tick bite, fever,
petechial rash, gastrointestinal symptoms, pancytopenia,
hyponatremia and elevated liver enzymes. Her RMSF
antibody showed positive IgM antibody and IgG serocon-
version during convalescence. She fulfilled the case
definition of RMSF. On the ninth day of illness, when
she developed swelling of her extremities, she matched the
clinical criteria of Kawasaki disease: fever more than
5 days, oral mucositis, skin rash, bulbar conjunctivitis and
swelling of the hands and feet. Her clinical diagnosis of
RMSF was followed by the diagnosis of Kawasaki disease
4 days after initiation of antimicrobial therapy for RMSF
and she showed clinical improvement during that interval.
Tick bite, petechial rash, pancytopenia, seroconversion for
RMSF and clinical improvement with doxycycline are the
distinct features of RMSF rather than evolving or incom-
plete KD. During the second phase of the illness, the
patient developed swelling of her extremities, and resolu-
tion of symptoms with IGIV and aspirin therapy which is
characteristic of KD.
The close temporal occurrence of RMSF and KD in this
patient suggests four possibilities: the association may be
entirely coincidental; a nonspecific serologic response to
RMSF in a patient with KD; RMSF leading to vasculitis
mimicking KD; RMSF etiologically related to KD as a
superantigen interacting with the host immune system.
The theory of coincidental occurrence of RMSF and KD in
this patient cannot be ruled out. It is possible that the
patient presented with incomplete features of KD during
early hospitalization and was undergoing various clinical
phases of KD. Although a nonspecific antibody response
can be seen in some of the patients with KD similar to
certain infectious diseases such as Epstein–Barr Virus
infection and collagen vascular disease, this patient had
clinical features of RMSF distinct from KD and she had
seroconversion for RMSF antibody. The patient lived in a
part of the United States where RMSF is not endemic. In
1981, Headings and Santosham described a patient with
KD with serologic evidence of recent RMSF, but that
patient did not have the clinical evidence of RMSF [3].
Both KD and RMSF are associated with vasculitis involving
small and medium sized blood vessels. In an experimental
investigation by Walker and colleagues, infection of
primary chick embryo monolayer cells showed dilatation
of the rough endoplasmic reticulum and cellular necrosis
of human endothelial cells [4,5]. Rickettsia-like bodies
have been found in biopsy specimens from the skin and
lymph nodes of patients with Kawasaki disease and these
microbodies were isolated from the peripheral blood of a
patient with Kawasaki disease [6,7]. Rickettsia-like bodies
were found in the monocytes of splenic pericapsular tissue
from a child with Kawasaki disease [8].
The clinical presentation of KD is very similar to a number
of diseases caused by exotoxins acting as superantigens,
such as toxic shock syndrome. The report by Rowley et al.
of IgA plasma cell infiltration of vascular walls in children
with KD suggests that KD is the result of the stimulation of
an antigen-driven immune response with plasma cell
involvement [9].
If one believes that this patient had vasculitis due to RMSF
and that her clinical resolution occurred after the
combination of doxycycline and IGIV, then the role of
IGIV in some patients with RMSF needs further explora-
tion. IGIV has been shown to be effective in other
superantigen related conditions such as Toxic Shock
Syndrome and autoimmune thrombocytopenic purpura
refractive to conventional management. IGIV may have
clinical benefits in vasculitic diseases such as RMSF by
exerting its effect on the vascular endothelium. There have
not been any published reports of the use of IGIV in
patients with RMSF.
We also did not find any literature documenting KD
following clinical RMSF with seroconversion. Our patient,
the first to be published, more likely represents KD
following RMSF rather than a RMSF-related vasculitis.
The patient had biphasic illness with two clearly separate
symptom complexes. RMSF responded quickly to doxycy-
cline and the KD responded quickly to IGIV.
Conclusions
This case report suggests that Kawasaki disease can occur
concurrently or immediately after a rickettsial disease such
as RMSF. This led us to hypothesize that the etiologic
agent of RMSF could act as a superantigen leading to
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some patients with RMSF who have severe vasculitis and
who are refractory to antimicrobial therapy, IGIV may
have potential benefits, and needs to be studied further.
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